Kyntra Bio, Inc. (KYNB) stock
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−1.16 (-36.25%)
Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –
Kyntra Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Kyntra Bio's price to sales ratio was 3.2× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 0.3× to 18.0×, with a median of 4.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | −1.1 |
| 2025 | Dec 31, 2025 | 4.3× | +3.3 |
| 2024 | Dec 31, 2024 | 1.0× | +0.4 |
| 2023 | Dec 29, 2023 | 0.6× | −11.7 |
| 2022 | Dec 30, 2022 | 12.2× | +7.6 |
| 2021 | Dec 31, 2021 | 4.6× | −23.7 |
| 2020 | Dec 31, 2020 | 28.3× | +17.8 |
| 2019 | Dec 31, 2019 | 10.5× | −18.5 |
| 2018 | Dec 31, 2018 | 28.9× | +0.4 |
| 2017 | Dec 29, 2017 | 28.6× | +20.7 |
| 2016 | Dec 30, 2016 | 7.8× | −3.0 |
| 2015 | Dec 31, 2015 | 10.8× | +7.3 |
| 2014 | Dec 31, 2014 | 3.5× | – |
See a number that looks wrong?